Vivos Therapeutics Inc has commercially launched of AireO2, a new patient management software technology that enables healthcare professionals to diagnose, treat, and monitor patients with obstructive sleep apnea (OSA) and its related conditions.
Developed in collaboration with medical billing for dental sleep software maker Lyon Dental, AireO2 contains features for billing services, practice management systems, and more.
[RELATED: Sleep Apnea Therapy Company Vivos Goes Public]
“We believe that Vivos’ sleep-specific AireO2 patient management technology represents a significant advancement in how medical and dental professionals will be able to treat sleep disorders,” says Kirk Huntsman, Vivos’ chairman and CEO, in a release. “Sleep apnea is a serious chronic disease that impacts much more than just sleep—it impacts patients’ quality of life and overall health. With AireO2, we believe that we can make it significantly easier for sleep disorder healthcare providers to manage their growing caseloads and increase the number of patients whom they can treat on any given day. We look forward to continuing the launch of AireO2 as a complement to our existing Billing Intelligence Service for our Vivos Integrated Practices and to actively pursuing AireO2 as a revenue source from other OSA-focused healthcare providers.”
Lindsay Williams, DDS, part of the Vivos Integrated Practice program, says in a release, “Vivos’ new technology has ultimately allowed me to see more patients and increase the quality of their care, all of the while boosting operational efficiency for my practice. Vivos’ innovative new platform can help the medical community as a whole to tackle this prevalent silent killer head-on in hopes of saving more lives and raising awareness of this deadly disease.”
